JSE-listed Clicks Group has released its Clicks interim results for the six months ending February 2025. They report impressive resilience and strategic accomplishments in the health and beauty retail sector. The group noted a 13.2% rise in headline earnings per share (HEPS). Clicks credits its robust earnings performance to several crucial factors. These include significant market share growth in its…
Tag: clicks
-
SA’s largest pharmacy chains have ambitious expansion plans
South Africa’s two largest pharmacy chains, Clicks and Dis-Chem, are pushing aggressive expansion plans, reflecting market optimism about their future growth. Both companies are enhancing their presence through new store rollouts and a strong focus on loyalty programmes, appealing to the increasing number of value-focused consumers in South Africa. Clicks has proven resilient with a cash-generative business model. Its strategic…
-
Clicks to sell stake in Unicorn Pharmaceuticals
The Clicks Group has announced plans to sell its shareholding in its pharmaceutical manufacturing subsidiary, Unicorn Pharmaceuticals. The sale is anticipated to be finalised by the end of July. This decision follows the Constitutional Court’s ruling in March 2023 in the Independent Community Pharmacy Association’s case against the Clicks Group case. Subsequently, the matter was referred to the director-general of…